EU signals last-resort backing for Greece - Financial TimesEU signals last-

resort backing for Greece - Financial TimesFinancial Times reports the European
Union made clear on Thursday it would not abandon Greece and let Athens'
mounting debt crisis jeopardise the eurozone, even as Germany and France played
down suggestions they had already formulated an emergency rescue plan. "It's quite
clear that economic policies are not just a matter of national concern but European
concern," Jose Manuel Barroso, European Commission president, told reporters in
Brussels. According to high-level EU officials, Greece would in the last resort receive
emergency support in an operation involving eurozone governments and the
Commission but not the International Monetary Fund.

SPPI Spectrum Pharma announces receipt of $16 mln from Asian partners
related to Apaziquone collaboration agreements announced in November
2009 (4.40 )
Co announces that it has received $15 mln from Nippon Kayaku in connection with
the collaboration agreement for apaziquone announced on November 10, 2009, and
$1 mln from Handok Pharmaceuticals announced on November 23, 2009. The
Company previously announced strategic collaboration agreements with Allergan
(AGN) for North America, Europe, and other key markets; Nippon Kayaku for Asian
countries; and Handok Pharmaceuticals for South Korea. Under terms of the three
agreements, in addition to the upfront payments received, Spectrum
Pharmaceuticals may receive potential milestone payments based on the
achievement of certain clinical, regulatory, and commercialization milestones of more
than $450 mln. Spectrum will also receive royalties on all ex-U.S. sales.

RBI lifts reserve ratio, rate rise seen next - Reuters.com

Reuters.com reports the Reserve Bank of India (RBI) surprised markets by raising
banks' cash reserve requirements by more than expected and warned of mounting
inflation, setting the stage for raising interest rates in the coming months. The
Reserve Bank of India (RBI) kept short-term interest rates steady at its quarterly
policy review but signalled hawkish intent that traders and analysts said could
result in increased interest rates even before its next policy review in April.
The RBI warned that monetary policy would be ineffective unless the government
cuts borrowing, on track to hit a record 4.5 trillion rupees ($97 billion) this fiscal
year, putting pressure on the government to rein in spending when it releases its
budget on Feb 26. "I think they're lining us up for something more in the not-too-
distant future," said Robert Prior-Wandesforde, senior Asia economist at HSBC in
Singapore, who expects a rate increase before the April meeting.

In reaction to strong earnings/guidance: ISSI +12.1%, SNV +8.4%, CADE

+8.2% (light volume), PMCS +6.7%, INFA +5.6%, EPAY +4.5% (light volume), RHI
+4.3% (upgraded to Hold at Stifel Nicolaus), JNPR +4.1%, COHR +4.1% (also
upgraded to Buy at B.Riley), VSEA +3.0%, AMZN +2.7%, EMN +2.4%, CHU +2.2%,
MSFT +2.2%, CHRD +2.2%, IMGN +1.4% (light volume)... Select metals/mining
related names showing modest strength: RTP +2.1%, MT +1.3%, VALE +1.2%,
BBL +0.8%... Select oil/gas names showing strength: TOT +1.7%, PBR +1.1%,
CVX +1.0%... Select India related names ticking higher following Reserve
Bank of India announcements: IBN +5.2% (India shares higher following India
Central bank announcement), INFY +1.5%... Other news: ATV +11.2% (Hearing
early strength attributed to positive newsletter mention), USU +11.1% (rebounding
following uranium stock's' weakness yesterday), ROSG +10.5% (fortifies patent
position with U.S. allowance of claims covering human microRNAs miR-21 and hcmv-
miR-UL112), TI +3.6% (Italy Govt can only use moral suasion at Telecom Italia -
WSJ.com), NBG +3.5% (EU signals last-resort backing for Greece - Financial Times),
SYT +2.2% (traded higher overseas), AVT +1.2% (Cramer makes positive
comments on MadMoney), ALOG +1.0% (Analogic and L-3 Communications to
upgrade complete L-3 examiner line of explosives detection systems)... Analyst
comments: MXIM +4.9% (upgraded to Overweight at GC Research), WMT +2.6%
(upgraded to Buy at Goldman), DAI +2.0%(upgraded to neutral at HSBC), TTWO
+2.0% (upgraded to Buy at Morgan Joseph).

In reaction to disappointing earnings/guidance: YTEC -43.0%, QTM -13.1%,

SNDK -12.5%, ACI -8.9%, GIGA -6.7% (light volume), ASIA -5.2%, TSRA -4.2%,
PAR -3.2% (also downgraded to Hold at ThinkEquity), PFS -2.6% (light volume),
HON -2.4%, WAB -2.1%, FLS -1.5%, COLM -1.2%... Select coal related names
ticking lower following ACI results: JRCC -3.0%, MEE -2.1%, WLT -1.4%, ICO
-1.0%, BTU -0.8%... Other news: THRX -7.4% (announces FDA complete response
letter for the telavancin new drug application is incomplete), PUK -2.4%, GSK -1.3%
(still checking for anything specific)... Analyst comments: FII -2.4% (downgraded
to Underperform from Market Perform at FBR), BKC -2.1% (downgraded to Perform
from Outperform at Oppenheimer), DGX -1.1% (downgraded to Hold from Buy at
Deutsche Bank).